[Buschke-Lowenstein tumor of the anal area].
Oberlin
P
P
Service de Dermatologie, Hôpital Bichat, Paris.
Crickx
B
B
Picard
C
C
Benhamou
G
G
Vilotte
J
J
Vissuzaine
C
C
Bilbault
P
P
Belaïch
S
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001005:Anus Neoplasms / Q000473:pathology / Q000628:therapy*; D001761:Bleomycin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D003218:Condylomata Acuminata / Q000473:pathology / Q000628:therapy*; D005050:Etretinate / Q000627:therapeutic use; D005472:Fluorouracil / Q000008:administration & dosage; D015654:Herpesvirus 6, Human / Q000302:isolation & purification; D006716:Homosexuality; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D010386:Pelvic Neoplasms / Q000556:secondary*; D011379:Prognosis
D001761:Bleomycin; D005050:Etretinate; D007372:Interferons; D002945:Cisplatin; D005472:Fluorouracil
Tumeur de Buschke-Löwenstein de la région anale.